TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says February 12, 1999